Industry Growth Insights published a new data on “Implantable Drug-Eluting Devices Market”. The research report is titled “Implantable Drug-Eluting Devices Market research by Types (Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices, Contraceptive Drug-Eluting Devices, Drug-Eluting Stents, Others), By Applications (Diabetes, Contraception, HIV/AIDS Prevention, Chronic Pain Management, Cardiovascular, Ophthalmology, Oncology, Others), By Players/Companies Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, Allergan, Bausch & Lomb, REVA Medical, MicroPort Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Drug-Eluting Devices Market Research Report
By Type
Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices, Contraceptive Drug-Eluting Devices, Drug-Eluting Stents, Others
By Application
Diabetes, Contraception, HIV/AIDS Prevention, Chronic Pain Management, Cardiovascular, Ophthalmology, Oncology, Others
By Companies
Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, Allergan, Bausch & Lomb, REVA Medical, MicroPort Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Drug-Eluting Devices Market Report Segments:
The global Implantable Drug-Eluting Devices market is segmented on the basis of:
Types
Implantable Drug Infusion Pumps, Intraocular Drug-Eluting Devices, Contraceptive Drug-Eluting Devices, Drug-Eluting Stents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Contraception, HIV/AIDS Prevention, Chronic Pain Management, Cardiovascular, Ophthalmology, Oncology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Medtronic
- Merck
- Bayer AG
- Johnson & Johnson
- Abbott
- Surmodics
- Boston Scientific Corporation
- Titan Pharmaceuticals, Inc.
- BIOTRONIK
- Allergan
- Bausch & Lomb
- REVA Medical
- MicroPort Medical
Highlights of The Implantable Drug-Eluting Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others
- By Application:
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Drug-Eluting Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Implantable drug-eluting devices (IDDEs) are medical devices that use a variety of technologies to remove drugs and other substances from the body. IDDEs can be placed in different parts of the body, including the stomach, small intestine, large intestine, and liver.
Some of the major companies in the implantable drug-eluting devices market are Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, Allergan, Bausch & Lomb, REVA Medical, MicroPort Medical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Drug-Eluting Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Drug-Eluting Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Drug-Eluting Devices Market - Supply Chain
4.5. Global Implantable Drug-Eluting Devices Market Forecast
4.5.1. Implantable Drug-Eluting Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Drug-Eluting Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Drug-Eluting Devices Market Absolute $ Opportunity
5. Global Implantable Drug-Eluting Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Drug-Eluting Devices Market Size and Volume Forecast by Type
5.3.1. Implantable Drug Infusion Pumps
5.3.2. Intraocular Drug-Eluting Devices
5.3.3. Contraceptive Drug-Eluting Devices
5.3.4. Drug-Eluting Stents
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Drug-Eluting Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
6.3.1. Diabetes
6.3.2. Contraception
6.3.3. HIV/AIDS Prevention
6.3.4. Chronic Pain Management
6.3.5. Cardiovascular
6.3.6. Ophthalmology
6.3.7. Oncology
6.3.8. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Drug-Eluting Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Drug-Eluting Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Drug-Eluting Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Drug-Eluting Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Drug-Eluting Devices Demand Share Forecast, 2019-2026
9. North America Implantable Drug-Eluting Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
9.4.1. Diabetes
9.4.2. Contraception
9.4.3. HIV/AIDS Prevention
9.4.4. Chronic Pain Management
9.4.5. Cardiovascular
9.4.6. Ophthalmology
9.4.7. Oncology
9.4.8. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Type
9.7.1. Implantable Drug Infusion Pumps
9.7.2. Intraocular Drug-Eluting Devices
9.7.3. Contraceptive Drug-Eluting Devices
9.7.4. Drug-Eluting Stents
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Drug-Eluting Devices Demand Share Forecast, 2019-2026
10. Latin America Implantable Drug-Eluting Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
10.4.1. Diabetes
10.4.2. Contraception
10.4.3. HIV/AIDS Prevention
10.4.4. Chronic Pain Management
10.4.5. Cardiovascular
10.4.6. Ophthalmology
10.4.7. Oncology
10.4.8. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Drug-Eluting Devices Market Size and Volume Forecast by Type
10.7.1. Implantable Drug Infusion Pumps
10.7.2. Intraocular Drug-Eluting Devices
10.7.3. Contraceptive Drug-Eluting Devices
10.7.4. Drug-Eluting Stents
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Drug-Eluting Devices Demand Share Forecast, 2019-2026
11. Europe Implantable Drug-Eluting Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Drug-Eluting Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
11.4.1. Diabetes
11.4.2. Contraception
11.4.3. HIV/AIDS Prevention
11.4.4. Chronic Pain Management
11.4.5. Cardiovascular
11.4.6. Ophthalmology
11.4.7. Oncology
11.4.8. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantabe Drug-Eluting Devices Market Size and Volume Forecast by Type
11.7.1. Implantable Drug Infusion Pumps
11.7.2. Intraocular Drug-Eluting Devices
11.7.3. Contraceptive Drug-Eluting Devices
11.7.4. Drug-Eluting Stents
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Drug-Eluting Devices Demand Share, 2019-2026
12. Asia Pacific Implantable Drug-Eluting Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Drug-Eluting Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
12.4.1. Diabetes
12.4.2. Contraception
12.4.3. HIV/AIDS Prevention
12.4.4. Chronic Pain Management
12.4.5. Cardiovascular
12.4.6. Ophthalmology
12.4.7. Oncology
12.4.8. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Drug-Eluting Devices Market Size and Volume Forecast by Type
12.7.1. Implantable Drug Infusion Pumps
12.7.2. Intraocular Drug-Eluting Devices
12.7.3. Contraceptive Drug-Eluting Devices
12.7.4. Drug-Eluting Stents
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Drug-Eluting Devices Demand Share, 2019-2026
13. Middle East & Africa Implantable Drug-Eluting Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Drug-Eluting Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Drug-Eluting Devices Market Size and Volume Forecast by Application
13.4.1. Diabetes
13.4.2. Contraception
13.4.3. HIV/AIDS Prevention
13.4.4. Chronic Pain Management
13.4.5. Cardiovascular
13.4.6. Ophthalmology
13.4.7. Oncology
13.4.8. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Drug-Eluting Devices Market Size and Volume Forecast by Type
13.7.1. Implantable Drug Infusion Pumps
13.7.2. Intraocular Drug-Eluting Devices
13.7.3. Contraceptive Drug-Eluting Devices
13.7.4. Drug-Eluting Stents
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Drug-Eluting Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Implantable Drug-Eluting Devices Market: Market Share Analysis
14.2. Implantable Drug-Eluting Devices Distributors and Customers
14.3. Implantable Drug-Eluting Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Surmodics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Boston Scientific Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Titan Pharmaceuticals, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. BIOTRONIK
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Allergan
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Bausch & Lomb
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. REVA Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. MicroPort Medical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
&nb
